Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC has converted 3 convertible bonds in Oxurion resulting in a EUR 75,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1].
Leuven, BELGIUM – July 8 2026 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Oxurion NV (Euronext Brussels: OXUR) (the “Company” or “Oxurion”), announces the below information, following the issuance of 29,685,310 new ordinary shares on July 7, 2026, for a total amount of EUR 75,000 pursuant to the Capital Commitment entered into with Atlas Special Opportunities, LLC.
Following completion of capital increase through the conversion of the convertible bonds, the total number of shares issued by Oxurion amounts to 140,734,891 outstanding ordinary shares carrying voting rights (compared to 111,049,581 outstanding ordinary shares previously). This number will be used as the denominator for the calculation of the percentages of shareholdings.
Therefore, Oxurion publishes the following updated information:
|
87,206,161.32 |
|
140,734,891 |
|
140,734,891 |
|
|
|
|
About Oxurion
Oxurion NV (Euronext Brussels: OXUR) is a company specializing in acquiring majority stakes in promising European pharmaceutical subcontractors. Oxurion's ambition is to build an integrated group of subcontractors serving healthcare players. The Group's headquarters are based in Leuven, Belgium. More information is available at www.oxurion.com.
Important information about forward-looking statements
Certain statements in this press release may be considered “forward-looking”. Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.
Additional Disclaimer
The planned investment in digital assets (such as Bitcoin and Ethereum) exposes the company to specific risks related to volatility, regulatory uncertainty, and cybersecurity. These factors may significantly affect the expected performance of the investments.
Please contact for additional information:
| Oxurion NV Pascal Ghoson Chief Executive Officer pascal.ghoson@oxurion.com |
[1] Press release Oxurion, 02/03/2023
This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: nXCekZ2cYprHm25xaZpsmmRql25oxpPHl2Kdm2JwlpjGbJpklGiXl53KZnJqlm5m
- Check this key: https://www.security-master-key.com.
- SECURITY MASTER Key: nXCekZ2cYprHm25xaZpsmmRql25oxpPHl2Kdm2JwlpjGbJpklGiXl53KZnJqlm5m
- Check this key: https://www.security-master-key.com.
Regulated information: Inside Information: - other releases
Full and original press release in PDF: https://www.actusnews.com/news/99190-oxur-pr_voting-rights-eng_20260708.pdf